Qlucore AB AI Stock Analysis
Want to see SE:QCORE full AI Analyst Report?
Qlucore AB (QCORE) AI Stock Analysis
Qlucore AB
(Nasdaq OMX AB:QCORE)
The score is driven primarily by weak financial performance: shrinking revenue, negative gross margins, losses several times larger than sales, and ongoing cash burn against a rapidly depleting equity base, which raises funding and dilution risk. Technicals reinforce the caution, with the price below all key moving averages and a negative MACD, although a deeply oversold stochastic hints at scope for a short-term bounce. Valuation adds no support given negative earnings and no dividend. The main positives — a debt-free balance sheet, moderating cash burn, and a recent return to modest top-line growth — are not yet enough to offset the execution risk in this early-stage micro-cap.
Qlucore AB (QCORE) vs. iShares MSCI Sweden ETF (EWD)
- Market Cap
- SEK 13.73M
- Dividend Yield
- ―
- Average Volume (3M)
- 26.16K
- Price to Earnings (P/E)
- -0.3
- Beta (1Y)
- 0.26
- Revenue Growth
- -18.34%
- EPS Growth
- 59.68%
- Country
- Sweden
- Employees
- 12
- Sector
- General
- Sector Strength
- 55
- Industry
- Software - Application
Qlucore AB Business Overview & Revenue Model
Company Description
Based in Lund, Sweden, Qlucore AB (publ) delivers advanced bioinformatics data analysis tools for global application in both scientific research and accurate medical diagnostics. Its product suite includes Qlucore Omics Explorer, an AI-powered bioinf...
Qlucore AB Financial Statement Overview
Summary
Financials are very weak. Revenue has collapsed from roughly SEK 14.4 million in fiscal 2024 to SEK 6.7 million in fiscal 2026, gross profit has turned negative, and the TTM net loss of about SEK 32.8 million is more than four times sales. Cash burn continues, with operating cash flow of about -SEK 10.3 million and free cash flow of about -SEK 13.8 million. The offsets are a nearly debt-free balance sheet (debt-to-equity around 0.04), equity funding roughly 78% of assets, a moderating burn rate, and a recent return to about 12% top-line growth on a TTM basis. However, shareholders' equity has fallen from about SEK 110.6 million in fiscal 2022 to SEK 33.5 million, leaving limited runway and real dilution or funding risk.
Income Statement
8Very NegativeBalance Sheet
45NeutralCash Flow
15Very Negative| Breakdown | TTM | Apr 2025 | Apr 2024 | Apr 2023 | Apr 2022 | Apr 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 7.57M | 6.74M | 10.21M | 14.37M | 14.12M | 12.67M |
| Gross Profit | -16.95M | -20.51M | -9.75M | 7.40M | 5.43M | 5.80M |
| EBITDA | -32.05M | -20.43M | -15.44M | -11.27M | -7.99M | -11.86M |
| Net Income | -32.77M | -36.52M | -20.54M | -15.68M | -11.66M | -15.94M |
Balance Sheet | ||||||
| Total Assets | 42.74M | 42.01M | 69.95M | 90.01M | 121.90M | 109.36M |
| Cash, Cash Equivalents and Short-Term Investments | 6.06M | 2.97M | 5.26M | 28.62M | 97.97M | 69.73M |
| Total Debt | 1.25M | 1.40M | 2.00M | 3.18M | 5.33M | 4.46M |
| Total Liabilities | 9.28M | 5.71M | 11.49M | 10.90M | 11.34M | 14.63M |
| Stockholders Equity | 33.47M | 36.30M | 58.47M | 79.11M | 110.56M | 94.73M |
Cash Flow | ||||||
| Free Cash Flow | -13.84M | -12.51M | -22.38M | -39.47M | -15.76M | -27.06M |
| Operating Cash Flow | -10.30M | -12.46M | -14.15M | -16.95M | -6.81M | -8.05M |
| Investing Cash Flow | -3.54M | -3.67M | -8.22M | -22.52M | -8.95M | -19.02M |
| Financing Cash Flow | 13.79M | 13.79M | -1.18M | -1.27M | 86.25M | -808.00K |
Qlucore AB Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:QCORE, the sentiment is Neutral. The current price of 0.32 is above the 20-day moving average (MA) of 0.32, below the 50-day MA of 0.35, and below the 200-day MA of 0.40, indicating a neutral trend. The MACD of -0.01 indicates Negative momentum. The RSI at 47.28 is Neutral, neither overbought nor oversold. The STOCH value of 76.15 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for SE:QCORE.
Qlucore AB Peers Comparison
Overall Rating
SE:VIT.B75Outperform
SE:CARA72.6Outperform
SE:MODEL47Neutral
SE:SUBGEN41Neutral
SE:QCORE41Neutral
SE:PREC39Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 75Outperform | SEK 12.31B | 25.95 | 9.27% | 1.18% | 5.55% | 18.93% | |
| 73Outperform | SEK 1.72B | 44.98 | ― | ― | ― | ― | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 47Neutral | SEK 165.84M | -8.20 | -83.32% | ― | -17.82% | 53.79% | |
| 41Neutral | SEK 58.11M | -0.23 | -34.88% | ― | ― | ― | |
| 41Neutral | SEK 13.73M | -0.32 | ― | ― | -18.34% | 59.68% | |
| 39Underperform | SEK 133.94M | -1.16 | -33.17% | ― | -11.14% | -152.87% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| SE:QCORE | Qlucore AB | 0.32 | -0.15 | -31.91% | |
| SE:PREC | Precise Biometrics AB | 0.49 | -1.64 | -76.96% | |
| SE:SUBGEN | AegirBio AB | 0.03 | -9.97 | -99.74% | |
| SE:MODEL | Modelon AB | 9.10 | -1.50 | -14.15% | |
| SE:VIT.B | Vitec Software Group AB Class B | 308.60 | 12.33 | 4.16% | |
| SE:CARA | Carasent AB | 25.75 | -1.55 | -5.68% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Sep 29, 2026
